Unknown

Dataset Information

0

RNA sequencing reveals niche gene expression effects of beta-hydroxybutyrate in primary myotubes.


ABSTRACT: Various forms of fasting and ketogenic diet have shown promise in (pre-)clinical studies to normalize body weight, improve metabolic health, and protect against disease. Recent studies suggest that β-hydroxybutyrate (βOHB), a fasting-characteristic ketone body, potentially acts as a signaling molecule mediating its beneficial effects via histone deacetylase inhibition. Here, we have investigated whether βOHB, in comparison to the well-established histone deacetylase inhibitor butyrate, influences cellular differentiation and gene expression. In various cell lines and primary cell types, millimolar concentrations of βOHB did not alter differentiation in vitro, as determined by gene expression and histological assessment, whereas equimolar concentrations of butyrate consistently impaired differentiation. RNA sequencing revealed that unlike butyrate, βOHB minimally impacted gene expression in primary adipocytes, macrophages, and hepatocytes. However, in myocytes, βOHB up-regulated genes involved in the TCA cycle and oxidative phosphorylation, while down-regulating genes belonging to cytokine and chemokine signal transduction. Overall, our data do not support the notion that βOHB serves as a powerful signaling molecule regulating gene expression but suggest that βOHB may act as a niche signaling molecule in myocytes.

SUBMITTER: Ruppert PM 

PROVIDER: S-EPMC8380668 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

RNA sequencing reveals niche gene expression effects of beta-hydroxybutyrate in primary myotubes.

Ruppert Philip Mm PM   Deng Lei L   Hooiveld Guido Jej GJ   Hangelbroek Roland Wj RW   Zeigerer Anja A   Kersten Sander S  

Life science alliance 20210818 10


Various forms of fasting and ketogenic diet have shown promise in (pre-)clinical studies to normalize body weight, improve metabolic health, and protect against disease. Recent studies suggest that β-hydroxybutyrate (βOHB), a fasting-characteristic ketone body, potentially acts as a signaling molecule mediating its beneficial effects via histone deacetylase inhibition. Here, we have investigated whether βOHB, in comparison to the well-established histone deacetylase inhibitor butyrate, influence  ...[more]

Similar Datasets

2021-08-10 | GSE179023 | GEO
| PRJNA741937 | ENA
| S-EPMC5971117 | biostudies-literature
| S-EPMC7242909 | biostudies-literature
| S-EPMC7010688 | biostudies-literature
2024-06-17 | MSV000095058 | MassIVE
2019-03-29 | GSE128462 | GEO
2018-01-17 | GSE109225 | GEO
| S-EPMC6986043 | biostudies-literature
| S-EPMC11435142 | biostudies-literature